The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Ex-divs to take up to 21.26 points off the index on Aug 13

Mon, 11th Aug 2014 10:53

LONDON, Aug 11 (Reuters) - The following FTSE 100 companies will goex-dividend on Wednesday, after which investors will no longer qualify for thelatest dividend payout. According to Reuters calculations at current market prices, the effect of the resulting adjustment to prices by market-makers would take between 19.75points and 21.26 points off the index. RIC Name Dividend Stock Max Shift Min Shift (GBp) Alternative ASHTEAD GRP. 9.25 0.1843183 0.1843183 ASTRAZENECA 53.1 2.6528569 2.6528569 BG GROUP 8.47 1.1412093 1.1412093 BT GROUP 7.5 2.3379043 2.3379043 DIAGEO 32 3.190853 3.190853 FRESNILLO 5 USc 0.0199875 0.0199875 GKN 2.8 0.1805475 0.1805475 IMI PLC 13.6 0.1469511 0.1469511 MEGGITT PLC 4.25 Yes 0.1355369 PEARSON 17 0.5472315 0.5472315 ROYAL DTCH SHL A 0.3995 3.7087209 3.7087209 USD ROYAL DTCH SHL B 0.47 USD 2.7188047 2.7188047 RIO TINTO 56.9 2.8104567 2.8104567 SCHRODERS 24 0.1073768 0.1073768 STANDRD CHART BK 28.8 USc Yes 1.3746169 Among FTSE 250 companies going ex-dividend are: RIC Name Dividend Unadjusted Currency Dividend CSR USD 0.052 COUNTRYWIDE GBp 14 DIRECT LINE GBp 14.4 MAN GROUP GBp 2.37 F&C COMM PRP GBp 0.5 FERREXPO USc 3.3 GREENE KING GBp 20.8 INFORMA GBp 4.16 KELLER GROUP GBp 8.4 KENNEDY WILSON GBp 2 LAW DEB CORP GBp 4.7 MILLENNIUM &COP GBp 2.08 MONEYSUP GRP GBp 2.31 NORTHGATE GBp 6.8 PZ CUSSONS GBp 5.23 RENTOKIL INITIAL GBp 0.77 TELECITY GBp 4.5 VESUVIUS GBp 5 (Reporting By Francesco Canepa)

Related Shares

More News
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announ...

3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.